1. Home
  2. SYRE vs DK Comparison

SYRE vs DK Comparison

Compare SYRE & DK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SYRE
  • DK
  • Stock Information
  • Founded
  • SYRE 2013
  • DK 2001
  • Country
  • SYRE United States
  • DK United States
  • Employees
  • SYRE N/A
  • DK N/A
  • Industry
  • SYRE Biotechnology: Pharmaceutical Preparations
  • DK Integrated oil Companies
  • Sector
  • SYRE Health Care
  • DK Energy
  • Exchange
  • SYRE Nasdaq
  • DK Nasdaq
  • Market Cap
  • SYRE 897.9M
  • DK 1.0B
  • IPO Year
  • SYRE 2016
  • DK 2006
  • Fundamental
  • Price
  • SYRE $12.67
  • DK $12.89
  • Analyst Decision
  • SYRE Buy
  • DK Hold
  • Analyst Count
  • SYRE 8
  • DK 11
  • Target Price
  • SYRE $50.00
  • DK $17.33
  • AVG Volume (30 Days)
  • SYRE 899.5K
  • DK 1.5M
  • Earning Date
  • SYRE 05-08-2025
  • DK 05-07-2025
  • Dividend Yield
  • SYRE N/A
  • DK 7.92%
  • EPS Growth
  • SYRE N/A
  • DK N/A
  • EPS
  • SYRE N/A
  • DK N/A
  • Revenue
  • SYRE N/A
  • DK $11,852,200,000.00
  • Revenue This Year
  • SYRE N/A
  • DK N/A
  • Revenue Next Year
  • SYRE N/A
  • DK N/A
  • P/E Ratio
  • SYRE N/A
  • DK N/A
  • Revenue Growth
  • SYRE N/A
  • DK N/A
  • 52 Week Low
  • SYRE $10.91
  • DK $11.03
  • 52 Week High
  • SYRE $40.49
  • DK $30.85
  • Technical
  • Relative Strength Index (RSI)
  • SYRE 36.18
  • DK 42.52
  • Support Level
  • SYRE $12.04
  • DK $11.94
  • Resistance Level
  • SYRE $13.29
  • DK $13.07
  • Average True Range (ATR)
  • SYRE 1.27
  • DK 1.15
  • MACD
  • SYRE 0.01
  • DK -0.05
  • Stochastic Oscillator
  • SYRE 26.02
  • DK 39.49

About SYRE Spyre Therapeutics Inc.

Spyre Therapeutics Inc is a biotechnology company that aims to create the next-generation of inflammatory bowel disease (IBD) products by combining antibody engineering, rational therapeutic combinations, and precision medicine approaches for patient selection. IBD is a chronic condition characterized by inflammation within the gastrointestinal tract, including two main disorders which are UC and CD. A range of pharmaceutical options to address IBD exists, including anti-inflammatory drugs, immunosuppressants, and biologics.

About DK Delek US Holdings Inc.

Delek US Holdings Inc is an integrated energy business focused on petroleum refining, transportation and storage; wholesale crude oil, intermediate, and refined products, and convenience stores retailing. The company owns and operates independent refineries that produce a variety of petroleum products for transportation and industrial markets in the United States. Delek's logistics segment sells portions of the petroleum products its refineries produce. The logistics segment generates revenue through gathering, transporting, and storing crude oil and intermediate products, as well as by marketing, storing, and distributing refined products. The company also offers a collection of retail fuel and convenience stores operating in the Southeast region of the United States.

Share on Social Networks: